Research Article
Systemic-Lupus-Erythematosus-Related Acute Pancreatitis: A Cohort from South China
Table 2
Comparison of demographic and clinical features in SLE patients with and without AP.
| | SLE with AP | SLE without AP | |
| | Female (%) | 25 (92.59%) | 20 (86.96%) | 0.42 | | Age on SLE diagnosis (y) | | | 0.26 | | GCs dose (mg) | | | 0.18 | | SLEDAI score | | | 0.03 | | SLICC/ACR damage index | | | 0.11 | | Mortality | 10 (37.04%) | 0 | 0.001 | | Fever (%) | 21 (77.78%) | 9 (39.13%) | 0.006 | | Neuropsychiatric (%) | 7 (25.93%) | 1 (4.35%) | 0.042 | | Pulmonary (%) | 11 (40.74%) | 5 (21.74%) | 0.13 | | Articular (%) | 16 (59.26%) | 16 (69.57%) | 0.32 | | Mucocutaneous involvement (%) | 18 (66.67%) | 16 (69.57%) | 0.54 | | Renal (%) | 24 (88.89%) | 20 (86.96%) | 0.59 | | Hepatological (%) | 19 (82.61%) | 8 (34.78%) | 0.01 | | Hematological (%) | 27 (100.00%) | 14 (60.87%) | 0.001 | | Serositis (%) | 17 (62.96%) | 6 (26.09%) | 0.01 | | Number of organs involved | | | 0.001 | | Positive anti-dsDNA (%) | 24 (88.89%) | 19 (82.61%) | 0.41 | | Positive anti-Sm (%) | 6/21 (28.57%) | 10 (43.48%) | 0.24 | | Positive anti-Ro (%) | 13/21 (61.90%) | 14 (60.87%) | 0.60 | | Positive anti-La (%) | 7/21 (33.33%) | 0 | 0.003 | | Positive ACL-IgG (%) | 4/21 (19.05%) | 1/22 (4.55%) | 0.168 | | Positive ACL-IgM (%) | 4/21 (19.05%) | 1/22 (4.55%) | 0.16 | | Positive anti- GPI (%) | 3/21 (14.29%) | 2/22 (9.09%) | 0.48 | | Low C3 (%) | 26/26 (100%) | 22 (95.65%) | 0.47 | | Low C4 (%) | 21/26 (80.77%) | 20 (86.96%) | 0.42 | | Elevated CRP (%) | 18/22 (81.82%) | 10/21 (47.62%) | 0.02 |
|
|
